Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.

American journal of hypertension - 1 Mar 2008

Lemaitre Rozenn N, Heckbert Susan R, Sotoodehnia Nona, Bis Joshua C, Smith Nicholas L, Marciante Kristin D, Hindorff Lucia A, Lange Leslie A, Lumley Thomas S, Rice Kenneth M, Wiggins Kerri L, Psaty Bruce M

Abstract excerpt

BACKGROUND: The benefits of beta-blocker therapy may depend on underlying genetic susceptibility. METHODS: We investigated the interaction of common variation in beta1 and beta2 adrenergic receptor (AR) genes with beta-blocker use on the risks of myocardial infarction (MI) and ischemic stroke in a case-control study. Participants were treated pharmacologically for hypertension, aged 30-79 years, with incident MI...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenergic beta-Antagonists
Share to Hypertension

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Logistic Models

Share to Myocardial Infarction

Share to Receptors, Adrenergic, beta-1

Share to Receptors, Adrenergic, beta-2

Share to Stroke

Share to Treatment Outcome

Source

Identifiers

PMID: 18219297
DOI: 10.1038/ajh.2007.71

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.PMID 18219297Read ↗

Adrenergic-Pathway Gene Variants Influence Beta-Blocker–Related Outcomes After Acute Coronary Syndrome in a Race-Specific MannerSemantic proximity Read ↗

beta(2)-Adrenergic receptor polymorphisms and determinants of cardiovascular risk: the Cardiovascular Health Study.Semantic proximity Read ↗

β-Adrenergic Receptor Polymorphisms: Cardiovascular Disease Associations and PharmacogeneticsSemantic proximity Read ↗

β-Adrenergic Receptor Gene Polymorphisms and β-Blocker Treatment Outcomes in HypertensionSemantic proximity Read ↗

The pharmacogenetics of β-adrenergic receptor antagonists in the treatment of hypertension and heart failure.Semantic proximity Read ↗

Association between polymorphisms in the beta2-adrenergic receptor gene with myocardial infarction and ischaemic stroke in women.Semantic proximity Read ↗

Prognostic relevance of β1-adrenergic receptor polymorphisms on cardiovascular outcome in patients treated with metoprolol after acute myocardial infarction - an observational study.Semantic proximity Read ↗

Association of beta-1 and beta-2 adrenergic receptor gene polymorphisms with myocardial infarction.Semantic proximity Read ↗

β-AR polymorphisms and glycemic and lipid parameters in hypertensive individuals receiving carvedilol or metoprolol.Semantic proximity Read ↗

Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension.Semantic proximity Read ↗

Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction.Semantic proximity Read ↗

Angiotensin II type-I receptor and ACE polymorphisms and risk of myocardial infarction in men and women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.